Kimberly Sue, MD, PhD
she/her/hers
Assistant Professor of Medicine (General Internal Medicine)Cards
About
Research
Publications
2024
Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study
Hill K, Minahan-Rowley R, Biegacki E, Heimer R, Sue K. Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study. Harm Reduction Journal 2024, 21: 148. PMID: 39148036, PMCID: PMC11328386, DOI: 10.1186/s12954-024-01052-4.Peer-Reviewed Original ResearchConceptsSequential explanatory mixed-methods studyExplanatory mixed-methods studyMixed-methods studyHealthcare providersHealthcare providers' experiencesHealthcare providers treating patientsSample of providersProviders treating patientsDrug supplyProvider experienceProvider knowledgeIn-depth interviewsImprove careSense of helplessnessConvenience sampleHealthcare educationThematic analysisInterview transcriptsQualitative phasePurposive samplingProvidersHealthcareOpioid supplyAbsence of literatureResultsSeventy-eightDevelopment of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis.
Chan C, Minahan-Rowley R, Biegacki E, Sue K, Weimer M. Development of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis. Substance Use & Addiction Journal 2024, 29767342241267077. PMID: 39087514, DOI: 10.1177/29767342241267077.Peer-Reviewed Original ResearchInjection drug use-related infective endocarditisSemi-structured interviewsInjection drug usePatient participationPatient websitesInjection practicesInfective endocarditisPatient education resourcesHelpfulness of informationHistory of injection drug useDrug useMixed-methods studyHealthcare cliniciansBaseline surveyOpioid use disorderPrevention strategiesInformation websitesEducational materialsCounseling patientsHospitalized adultsPromote educationWebsite sectionsCliniciansSurvey feedbackUse disorderDrawing on Black and Queer Communities' Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.
Johnson S, Sue K. Drawing on Black and Queer Communities' Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies. The AMA Journal Of Ethic 2024, 26: e580-586. PMID: 38958427, DOI: 10.1001/amajethics.2024.580.Peer-Reviewed Original ResearchIn Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)
Dunham K, Hill K, Kazal H, Butner J, Hull I, Sue K, Li L, Doneski K, Dinges B, Rife-Pennington T, Kung S, Thakarar K. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction). Substance Use & Addiction Journal 2024, 45: 328-336. PMID: 38747578, DOI: 10.1177/29767342241252590.Peer-Reviewed Original ResearchPrevention CenterRates of fatal overdoseSubstance Use and AddictionDrop-in serviceEvidence-based strategiesHarm reduction strategiesMultidisciplinary Education and ResearchUnited StatesLifesaving servicesMedical careAdvocacy effortsIncrease accessPosition statementSocial servicesFatal overdoseEducation and ResearchDrug supplyTrained personnelPWUDPolicy changesFederal levelReduction strategiesInternational dataSterile suppliesServices“It’s Like A Partnership”: Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs
Dunham K, Rivas C, Medina Blanco P, Kolod B, Salvati C, Clark K, Sue K, Hagaman A, Weiss J. “It’s Like A Partnership”: Exploring the Primary Care Experiences and Patient-Defined Goals of People Who Use Drugs. Journal Of General Internal Medicine 2024, 39: 1681-1689. PMID: 38578536, PMCID: PMC11255174, DOI: 10.1007/s11606-024-08743-5.Peer-Reviewed Original ResearchPrimary care goalsPrimary care experiencesPrimary careSemi-structured interviewsCare goalsCare experiencesPatient-defined goalsDesignA qualitative studyOrganizational-level supportPatient health outcomesPrimary care providersPatient-provider collaborationThematic analysis approachHarm reduction settingsBackgroundPrimary carePatient involvementCare outcomesCare teamCare providersHealthcare goalsHealth outcomesHealthcare decisionsDeductive codingQualitative studyHarm reduction
2023
In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction)
Hill K, Dunham K, Brokos Z, Butner J, Hull I, Sue K, Li L, Thakarar K. In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction). Substance Use & Addiction Journal 2023, 45: 4-9. PMID: 38258861, DOI: 10.1177/29767342231212787.Peer-Reviewed Original ResearchHarm reduction strategiesPosition statementSerious adverse eventsImportant harm reduction strategyPublic health practitionersAdverse eventsUnregulated drug supplyFatal overdosesHealthcare providersComposition of drugsHealth consequencesHealth practitionersDrugsDrug supplyInsufficient dataDrug checkingUnited StatesClinical considerations for the management of xylazine overdoses and xylazine‐related wounds
Sue K, Hawk K. Clinical considerations for the management of xylazine overdoses and xylazine‐related wounds. Addiction 2023, 119: 606-608. PMID: 37939387, DOI: 10.1111/add.16388.Peer-Reviewed Original ResearchHousing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study
Chayama K, Ng C, Fleming T, Small W, Sue K, McNeil R. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study. Harm Reduction Journal 2023, 20: 126. PMID: 37679789, PMCID: PMC10483728, DOI: 10.1186/s12954-023-00862-2.Peer-Reviewed Original ResearchConceptsSyringe services programSyringe distribution programsInjecting equipmentSingle room occupancy hotelsDrug-related risksDistribution programHarm reduction measuresHarm reduction supportsLow-threshold accessMethodsBetween JanuaryPWIDDrug useSyringe possessionPeer staffMost participantsIllicit drugsDrugsService programsSyringesSupportive housingParticipantsImproving the Health of People Who Inject Drugs Through COVID-19–Related Policies
Hill K, Thakarar K, Eslinger H, Prosperino L, Sue K. Improving the Health of People Who Inject Drugs Through COVID-19–Related Policies. Public Health Reports 2023, 138: 862-864. PMID: 37610106, PMCID: PMC10576482, DOI: 10.1177/00333549231192468.Commentaries, Editorials and LettersRecognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut
Dowton A, Doernberg M, Heiman E, Barelli P, Golden M, Wang H, Leventhal J, Morford K, Sue K. Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut. Journal Of Addiction Medicine 2023, 17: 739-741. PMID: 37934550, DOI: 10.1097/adm.0000000000001198.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersDrug useCase report presentsIndex of suspicionInjection drug useDrug supplyCare management strategiesHarm reduction strategiesOverdose presentationsCutaneous manifestationsWithdrawal syndromeClinical complicationsCase reportIntravenous useWound carePatientsTreatment of woundsInfectious diseasesChronic woundsXylazineSkin woundsWoundsMore reportingDiagnosis
Links & Media
News
- July 05, 2024
Weleff Edits New Issue of AMA Journal of Ethics
- May 07, 2024Source: U.S. News and World Report
Almost All Counterfeit Oxycontin Pills Contain Fentanyl
- April 30, 2024
Amid Opioid Overdose Crisis, Yale Program in Addiction Medicine Advises State on Drug Company Settlement Spending
- February 23, 2024
Department of Internal Medicine Promotions and Appointments (February 2024)